A Nutritional Intervention Based on the Principles of Mediterranean Diet as a Putative Regulator of Craving and Redox Status of Patients Under Medication-assisted Treatment With Methadone and Buprenorphine: The Study Protocol of a Randomized Controlled Trial (the MED-DOPE Study)
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Craving
研究概览
简要总结
The MED-DOPE (MEDiterranean diet-driven Detoxification of OPioid addicted patiEnts) study is a randomized controlled trial that aims to investigate the role of a nutritional intervention based on the principles of Mediterranean diet on craving, which is the primary outcome, and blood redox status of opioid-addicted patients under medication-assisted treatment with buprenorphine and methadone. In detail, the patients of the intervention group will consume three meals per day (i.e., breakfast, lunch and dinner) based on the principles of Mediterranean diet for 90 days. The patients of the control group will follow their normal nutritional habits. Craving as the primary outcome, quality of sleep and biochemical parameters such as blood redox status will be evaluated. It is hypothesized that the applied nutritional intervention will reduce craving, probably through the improvement of blood redox status, of the patients of the intervention group compared to the patients of the control group.
详细描述
Background: Methadone and buprenorphine are considered as the "gold standard" medication-assisted treatment (MAT) for patients with opioid use disorders (OUDs). Patients who suffer from OUDs usually experience serious health consequences in the psychosocial and the biochemical level. Specifically, they are at 10-fold higher mortality risk than those of the general population. Moreover, there are inconsistencies related to the efficacy of MAT (i.e., methadone and buprenorphine) on retention to treatment and opioid craving, that is a major psychosocial parameter to be improved towards successful rehabilitation. Craving is a central psychosocial component for addiction characterized by a strong urge to use an illicit substance that induces addiction. It appears that although MAT partially normalizes this parameter, patients with OUDs continue to experience craving for opioids leading to drug-seeking behavior and relapse. Furthermore, opioids such as heroine induce oxidative stress, a common toxic biochemical outcome. However, this is the case also for methadone and buprenorphine, although in a lower extent compared to heroine. Therefore, opioid-addiction induced oxidative stress seems to be rather neglected and needs further attention. Oxidative stress is a result of excessive reactive oxygen species generation, which may cause protein and lipid oxidation and oxidative modification of DNA. To that end, the use of plant-derived compounds as auxiliary therapeutic approaches, in combination with methadone and buprenorphine could be a promising approach towards enhancement of the effectiveness of MAT. The biological plausibility for the adoption of such a nutritional practice relies on the fact that plant components namely polyphenols exert potent antioxidant properties against oxidative stress. It has been clearly shown that pomegranate juice is such a physical product. A nutritional approach on the basis of Mediterranean diet could also be considered as an alternative approach towards rehabilitation from addiction to opioids. Indeed, Mediterranean diet has been associated with better health outcomes. Its beneficial effects on human health have largely been attributed to the antioxidant properties of its components, mainly polyphenols.
Objectives: The MED-DOPE (MEDiterranean diet-driven Detoxification of OPioid addicted patiEnts) study aims to investigate the role of a nutritional intervention based on the principles of Mediterranean diet on craving and blood redox status of patients with OUDs under buprenorphine and methadone. This diet scheme is rich in antioxidant compounds that, along with medication (i.e., methadone and buprenorphine), could putatively act beneficially on several health parameters of the patients with OUDs.
Methods: Three meals (i.e., breakfast, lunch and dinner) will be administered daily for 90 days to patients with OUDs under methadone and buprenorphine. In two time points namely Days 1 and 90 the patients will form the heroine craving questionnaire to assess craving, which is the primary outcome of MED-DOPE study. Blood samples will also be collected from the participants in order to measure redox biomarkers (i.e., glutathione concentration, total antioxidant capacity, concentraiton of protein carbonyls, glutathione reductase activity and glutathione peroxidase activity).
Anticipated Outcome: It is hypothesized that the applied nutritional intervention will reduce craving probably through the improvement of blood redox status.
Conclusion: MED-DOPE is a hypothesis-driven and evidence-based project that proposes a nutrition-based solution for craving amelioration in patients with OUDs under MAT, potentially assisting towards their successful rehabilitation and societal reintegration.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 20 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Over 20 years of age
- •Long-term heroine or other opioid drug use
- •Suffering from physical and mental dependence due to chronic opioid use
排除标准
- •Serious medical problems, such as infection by human immunodeficiency virus or hepatitis B virus
- •Current use of anti-inflammatory medication
- •Relapse to other addictive substances (i.e., opioids, methamphetamine, benzodiazepines, cannabis, tetrahydrocannabinol, amphetamine) - To rule out the use of such substances, all participants will undergo weekly urine tests during the three-month period of the trial
研究组 & 干预措施
Intervention - Nutrition
The intevention group will comprise patients under medication-assisted treatment (MAT) who are active members of the therapeutic units of the Greek Organization Against Drugs (OKANA). The participants will be stratified into two subgroups, i.e., methadone maintenance treatment (MMT) and buprenorphine maintenance treatment (BMT), according to the maintenance treatment program they attend. The nutritional intervention based on the principles of Mediterranean diet will be administered to the participants of both MMT and BMT subgroups of the intervention group. The patients will consume meals three times (i.e., breakfast, lunch and dinner) per day for 90 days (i.e., three months).
干预措施: A nutritional intervention based on the principles of Mediterranean diet (Other)
No intervention - Control group
The control group will comprise patients under medication-assisted treatment (MAT) who are active members of the therapeutic units of the Greek Organization Against Drugs (OKANA). The participants will be stratified into two subgroups, i.e., methadone maintenance treatment (MMT) and buprenorphine maintenance treatment (BMT), according to the maintenance treatment program they attend. No intervention wil be applied. The patients will follow their normal nutritional habbits.
结局指标
主要结局
Craving
时间窗: Changes between Day 1 (pre) and Day 90 (post) will be assessed.
The effects of the applied nutritional intervention on craving will be assessed through the Heroin Craving Questionnaire (HCQ), which is a validated self-reported instrument. It is consisted of 45 questions divided in 5 dimensions, namely desire to use heroine, intentions and planning to use heroine, anticipation of positive outcome, relief from withdrawal or dysphoria, and lack of control overuse. The score is calculated with a 7-point Likert scale ranging from 1 (i.e., strongly disagree) to 7 (i.e., strongly agree) and the higher the score, the worse the outcome. HCQ will be completed by the volunteers of both the experimental and control groups at two timepoints as follows: Before the start of the experiment (i.e., Day 1 or pre) and at the end of the experiment (i.e., day 90 or post).
次要结局
- Quality of Sleep(Changes between Day 1 (pre) and Day 90 (post) will be assessed.)
- Blood GSH concentration(Changes in GSH concentration will be compared between Day 1 (pre) and Day 90 (post).)
- Concentration of protein carbonyls in blood(Changes in protein carbonyl concentration will be compared between Day 1 (pre) and Day 90 (post).)
- Total antioxidant capacity of blood(Changes in TAC will be compared between Day 1 (pre) and Day 90 (post).)
- Activity of glutathione reductase(Changes in glutathione reductase activity will be compared between Day 1 (pre) and Day 90 (post).)
- Activity of glutathione peroxidase(Changes in glutathione peroxidase activity will be compared between Day 1 (pre) and Day 90 (post).)
研究者
Aristidis Veskoukis
Assistant Professor
University of Thessaly
